Serviceeinschränkungen vom 12.-22.02.2026 - weitere Infos auf der UB-Homepage
American Psychological Association 6th edition

Denicolò, S., Nair, V., Leierer, J., Rudnicki, M., Kretzler, M., Mayer, G., Ju, W., & Perco, P. (2023). Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis. Biomolecules (2218-273 X), 13(1), 89-100. https://doi.org/10.3390/biom13010089

ISO-690 (author-date, English)

DENICOLÒ, Sara, NAIR, Viji, LEIERER, Johannes, RUDNICKI, Michael, KRETZLER, Matthias, MAYER, Gert, JU, Wenjun und PERCO, Paul, 2023. Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis. Biomolecules (2218-273 X). 1 Januar 2023. Vol. 13, no. 1, p. 89-100. DOI 10.3390/biom13010089.

Modern Language Association 9th edition

Denicolò, S., V. Nair, J. Leierer, M. Rudnicki, M. Kretzler, G. Mayer, W. Ju, und P. Perco. „Assessment of Fibrinogen-Like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis.“. Biomolecules (2218-273 X), Bd. 13, Nr. 1, Januar 2023, S. 89-100, https://doi.org/10.3390/biom13010089.

Mohr Siebeck - Recht (Deutsch - Österreich)

Denicolò, Sara/Nair, Viji/Leierer, Johannes/Rudnicki, Michael/Kretzler, Matthias/Mayer, Gert u. a.: Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis., Biomolecules (2218-273 X) 2023, 89-100.

Emerald - Harvard

Denicolò, S., Nair, V., Leierer, J., Rudnicki, M., Kretzler, M., Mayer, G., Ju, W. und Perco, P. (2023), „Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis.“, Biomolecules (2218-273 X), Vol. 13 No. 1, S. 89-100.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.